Jiangsu Recbio Technology Co., Ltd. engages in the research and development of vaccines. The company is headquartered in Taizhou, Jiangsu and currently employs 507 full-time employees. The company went IPO on 2022-03-31. The firm is still in the research and development stage. The firm's vaccine pipeline includes recombinant human papillomavirus (HPV) 9-valent vaccine, novel adjuvanted recombinant HPV 9-valent vaccine, recombinant HPV bivalent (Types 16/18) vaccine, recombinant HPV bivalent (Types 6/11) vaccine, novel adjuvanted recombinant HPV quadrivalent vaccine, novel adjuvanted recombinant shingles vaccine, novel adjuvanted recombinant respiratory syncytial virus vaccine, recombinant metapneumovirus vaccine, recombinant human cytomegalovirus vaccine, recombinant bicomponent COVID-19 vaccine, recombinant hepatitis B virus vaccine, and others.
02179.HK stock price ended at $4.94 on 목요일, after rising 0.00%
On the latest trading day Feb 12, 2026, the stock price of 02179.HK rose by 0.00%, climbing from $4.94 to $4.94. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $4.94 and a high of $4.94. Alongside this price increase, trading volume also rose by 22.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, -- shares were traded, amounting to a market value of approximately $1.5B.
02179.HK 기술적 시그널
기술적 시그널 요약
구매 신호 1
중립 신호 2
매도 신호 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
02179.HK은 현재 1개의 매수 신호와 4개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 상승 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 --입니다. 전반적으로 기술적 지표들은 중기적으로 Sell 전망을 나타내고 있습니다.
02179.HK에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 02179.HK 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.